Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group announced that all proposed resolutions were passed during their recent extraordinary general and class meetings held on December 24, 2024. The meetings, attended by a significant number of shareholders and authorized proxies, reflected strong shareholder engagement with 53.01% of voting rights exercised. This development is likely to be of interest to investors tracking the company’s governance and shareholder activities.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.